AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
55 hedge funds and large institutions have $21.2M invested in Asterias Biotherapeutics Inc. Series A in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
38% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 16
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $82K
Holders
55
Holding in Top 10
1
Calls
–
Puts
$82K
Top Buyers
| 1 | +$695K | |
| 2 | +$25.6K | |
| 3 | +$23.5K | |
| 4 |
ST
Spot Trading
Chicago,
Illinois
|
+$17.3K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
+$12.9K |
Top Sellers
| 1 | -$269K | |
| 2 | -$253K | |
| 3 | -$75K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$39.7K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$32.2K |